相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells
Patrik Zeyen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Novel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation
Tran Khac Vu et al.
MEDICINAL CHEMISTRY (2021)
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina et al.
CHEMMEDCHEM (2021)
HDAC6 as privileged target in drug discovery: A perspective
Sravani Pulya et al.
PHARMACOLOGICAL RESEARCH (2021)
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke et al.
CANCERS (2021)
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Andrey D. Bondarev et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Exploration of certain 1,3-oxazole-and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Duong Tien Anh et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and evaluation of novel indirubin-based N- hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents
Duong Tien Anh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
An Overview of HDAC Inhibitors and their Synthetic Routes
Xiaopeng Peng et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
Doan Thanh Hieu et al.
CHEMISTRY & BIODIVERSITY (2019)
Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents
Doan Thanh Hieu et al.
BIOORGANIC CHEMISTRY (2018)
Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
Doan Thanh Hieu et al.
CHEMISTRY & BIODIVERSITY (2018)
Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)-3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis
Do T M Dung et al.
MEDICINAL CHEMISTRY (2018)
Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents
Giang Le-Nhat-Thuy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Novel hydroxamic acids incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)-3-hydroxyimino-indolin-2-ones: synthesis, biological evaluation, and SAR analysis
Do Thi Mai Dung et al.
JOURNAL OF CHEMICAL SCIENCES (2018)
Quantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries
H. Pham-The et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2017)
Efficient conformational sampling and weak scoring in docking programs? Strategy of the wisdom of crowds
Ludovic Chaput et al.
JOURNAL OF CHEMINFORMATICS (2017)
Exploration of some indole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Tran Thi Lan Huong et al.
CHEMICAL PAPERS (2017)
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Julian Blagg et al.
CANCER CELL (2017)
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity
Tran-Thi-Lan Huong et al.
BIOORGANIC CHEMISTRY (2017)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Thiol Versus Hydroxamate as Zinc Binding Group in HDAC Inhibition: An Ab Initio QM/MM Molecular Dynamics Study
Wenjing Gong et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)
An Aggregation Advisor for Ligand Discovery
John J. Irwin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as Histone Deacetylase Inhibitors and Antitumor Agents
Do T. M. Dung et al.
MEDICINAL CHEMISTRY (2015)
HDAC inhibitors still need a home run, despite recent approval
Malini Guha
NATURE REVIEWS DRUG DISCOVERY (2015)
Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth
Xue-Wen Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011-2013)
Sergio Valente et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Synthesis, bioevaluation and docking study of 5-substitutedphenyl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Nguyen-Hai Nam et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Benjamin E. L. Lauffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
Christopher J. Millard et al.
MOLECULAR CELL (2013)
New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents
Truong Tung et al.
Medicinal Chemistry (2013)
Structure of HDAC3 bound to co-repressor and inositol tetraphosphate
Peter J. Watson et al.
NATURE (2012)
Synthesis and pharmacological evaluations of novel 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as a new class of anti-cancer agents
Chittipaka Rajitha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Zinc Chelation with Hydroxamate in Histone Deacetylases Modulated by Water Access to the Linker Binding Channel
Ruibo Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain
Matthew J. Bottomley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity
Anja Schuetz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
An alternative method for the evaluation of docking performance: RSR vs RMSD
Dilmurat Yusuf et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases
JR Somoza et al.
STRUCTURE (2004)
ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases
NH Nam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds
NH Nam et al.
ARCHIVES OF PHARMACAL RESEARCH (2004)
Current targets for anticancer drug discovery
NH Nam et al.
CURRENT DRUG TARGETS (2003)
分享论文
